Cargando…
Novel DNA Bis-Intercalator XR5944 as a Potent Anticancer Drug—Design and Mechanism of Action
This review is dedicated to Professor William A. Denny’s discovery of XR5944 (also known as MLN944). XR5944 is a DNA-targeted agent with exceptionally potent antitumor activity and a novel DNA binding mode, bis-intercalation and major groove binding, as well as a novel mechanism of action, transcrip...
Autores principales: | Buric, Adam J., Dickerhoff, Jonathan, Yang, Danzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304338/ https://www.ncbi.nlm.nih.gov/pubmed/34299405 http://dx.doi.org/10.3390/molecules26144132 |
Ejemplares similares
-
Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator
por: Lin, Clement, et al.
Publicado: (2014) -
First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action
por: Verborg, W, et al.
Publicado: (2007) -
Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines
por: Harris, S M, et al.
Publicado: (2005) -
Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes
por: Dickerhoff, Jonathan, et al.
Publicado: (2021) -
Editorial: NAR Cancer and epigenetics and cancer
por: Yang, Danzhou, et al.
Publicado: (2022)